MicroStent — a Novel Device Designed for Treatment of CLTI BTK
From Policlinico Abano Terme Padova Italy, Onze Lieve Vrouwziekenhuis (OLV) Aalst Belgium, Karolinen Hospital Arnsberg Germany, Ziekenhuis Oost-Limburg (ZOL) Genk Belgium…
Patterns of Failure in Deep Venous Arterialization and Implications for Management
The primary objective of this study was to describe a novel classification system to characterize patterns of failure in deep venous arterialization (DVA) and suggest intervent…
Preoperative C-Reactive Protein Levels Predict Readmission Following Elective Vascular Surgery
C-reactive protein (CRP) levels may be reduced with long-term administration of ubiquinone (CoQ10) in patients with chronic ischemic heart disease, but the impact of a sh…
Outcomes of Orbital Atherectomy in Patients With Critical Limb Threatening Ischemia and Diabetes
Patients with diabetes and critical limb threatening ischemia (CLTI) are at significantly higher risk of limb loss and death. We evaluate the outcomes of orbital atherect…
Systematic Meta-analysis—A Scientific Gold Standard for All Therapies?
From the Department of Angiology, Clinic for Cardiology and Angiology II, University Heart Center Freiburg-Bad Krozingen, Bad Krozingen, Germany. Disclosure: The author has …
Cost-Effectiveness of Critical Limb Ischemia Treatments—Critical Gaps Remain
From the Departments of Vascular Medicine, and Vascular and Endovascular Surgery, Massachusetts General Hospital, Boston, Massachusetts. Disclosure: The authors have completed…
Racial Disparities in Risk for Major Amputation or Death After Endovascular Interventions
Objectives. Previous studies have suggested that Black patients with peripheral artery disease (PAD) may have worse outcomes than White patients. The aim of this study was to…
PAD Awareness Month 2021
September is PAD Awareness Month and the CLI Global Society would like to bring attention to the warning signs of peripheral artery disease, the predecessor of critical limb ischem…